Cancer Grand Challenges
@cancergrand.bsky.social
420 followers 2 following 16 posts
Daring to solve some of the most complex challenges in cancer research |  Founded by Cancer Research UK & The NCI https://www.cancergrandchallenges.org/
Posts Media Videos Starter Packs
cancergrand.bsky.social
New research from team PROMINENT (@nlbigas.bsky.social), published in @nature.com, uncovers clues why men face a higher risk of bladder cancer and reveals that tobacco smoke acts as a promoter, not an initiator, in bladder cancer development.

Read more: www.cancergrandchallenges.org/news/early-c...
cancergrand.bsky.social
“If we can stop cachexia, we can help patients live better — and longer.” - Tobias Janowitz, Co-Lead of team CANCAN.

If you have access, discover how their work could change the way we treat one of cancer’s most overlooked challenges 👉 www.thetimes.com/uk/science/a... #CancerGrandChallenges
cancergrand.bsky.social
#CancerGrandChallenges IMAXT in @nature.com:
Using CloneSeq-SV, the team tracked ovarian cancer clones and found:

• Resistant clones often exist from diagnosis
• ctDNA spotted recurrence ~8 months earlier than imaging
• Actionable drivers (e.g. ERBB2) can be revealed

www.nature.com/articles/s41...
cancergrand.bsky.social
Targeted protein degraders could change how we treat childhood cancers.

John Buell of team KOODAC explains how our global team is working to develop safer, more effective therapies through #CancerGrandChallenges.

Find out more: koodac.com/scientific-e...
cancergrand.bsky.social
Today marks the 1st #CancerCachexiaAwarenessDay. Cachexia affects up to 80% of people with advanced cancer.

Our #CANCAN team is uncovering its biology & building the world’s first virtual cachexia institute.

🔗 www.cancergrandchallenges.org/news/demysti...
cancergrand.bsky.social
This Childhood Cancer Awareness Month, we’re highlighting progress against childhood solid tumours.

Our teams are working to advance next-gen CAR-T therapies & protein degraders—bringing hope for a future with safer, more effective treatments www.cancergrandchallenges.org/news/tacklin...
cancergrand.bsky.social
Published today in @aacrjournals.bsky.social Imran Noorani & @magnushaughey.bsky.social share the first evidence that ecDNA can build up in the healthy brain before tumours form in #glioblastoma — pointing to new early intervention strategies.

👉 www.cancergrandchallenges.org/news/ecdna-u...
cancergrand.bsky.social
Interesting @economist.com piece on #CancerGrandChallenges team Mutographs, Phil Jones (@sangerinstitute.bsky.social) & Sci Committee Chair Charles Swanton. Their work reshapes how we think about cancer’s origins - A great read if you have access.

👉 www.economist.com/science-and-...
cancergrand.bsky.social
New opinion piece by Tobias Janowitz at @cshlnews.bsky.social‬ & team CANCAN: Of Hope from Fading Will.

How cancer influences brain–body communication, why #cachexia may begin as an adaptive response, and how patient-reported symptoms can guide new interventions
👉 www.cell.com/neuron/fullt...
cp-neuron.bsky.social
We are proud to present a Special Issue on Cancer Neuroscience, curated by editors Bennie Babayan & Ted Dobie. This issue offers a snapshot of the field through a collection of Perspectives, Reviews, and NeuroViews: cell.com/neuron/issue.... See below for details on the pieces:
cancergrand.bsky.social
Congratulations to #CancerGrandChallenges MATCHMAKERS team member Regina Barzilay for making the 2025 #TIME100 list of global #AI leaders!

At ‪@aihealthmit.bsky.social‬, Regina has advanced cancer prediction and antibiotic discovery—and is now tackling our TCR challenge to transform #immunotherapy
aihealthmit.bsky.social
We're thrilled to share that @aihealthmit.bsky.social faculty lead Regina Barzilay has been included in TIME's list of #TIME100AI for 2025! 👏
📢Full Announcement: jclinic.mit.edu/regina-barzi...
📰More from TIME: time.com/collections/... #AISky
Photo of Regina Barzilay seated at her desk looking at the camera. The photo is framed by a black and red graphic that also reads "TIME100/AI 2025"
cancergrand.bsky.social
@natrevendo.nature.com‬ examines the links between obesity, T2DM, inflammation & microbiome disruption to rising early-onset colorectal cancer.

Featuring teams PROSPECT, CANCAN, and co-authors 👉 www.nature.com/articles/s41... #EOCRC #TeamScience
cancergrand.bsky.social
An interesting perspective in Molecular Cell from Cristina Mayor-Ruiz (team PROTECT), Georg E. Winter (team KOODAC), Alessio Ciulli (team KOODAC and co-authors - Opportunities in proximity modulation: Bridging academia and industry #CancerGrandChallenges
irbbarcelona.org
🤝 #IRBBarcelona Group Leader Cristina Mayor-Ruiz has co-authored a Perspective in #MolecularCell proposing the creation of a #EuropeanAlliance to accelerate the development of proximity-induced therapies.

More information here 🔗 www.irbbarcelona.org/en/news/scie...

🧪 #TargetedProteinDegradation
cancergrand.bsky.social
“...exploring why people don’t get cancer... could give us a greater understanding... and could potentially lead to new ways to think about cancer prevention” - Karen Vousden, @crick.ac.uk & #CancerGrandChallenges Scientific Committee Member talking about our cancer avoidance challenge.
undark.org
Historically, cancer research has probed the drivers of the disease’s evolution. But some scientists are widening their scope to study patients who survive against the odds. 

🔗: https://undark.org/2025/08/11/cancer-super-survivors/
cancergrand.bsky.social
Fascinating interview! Howard Chang shares insights on ecDNAs and his long-standing collaboration with Paul Mischel, both of which were central to his time as a co-investigator on #CancerGrandChallenges team eDyNAmiC whilst at Stanford University.
natrevdrugdiscov.nature.com
From gene hunter to drug hunter
www.nature.com/articles/d41...

Howard Chang, Amgen’s new CSO, discusses genetic target discovery, extrachromosomal DNA and technology development
cancergrand.bsky.social
After nearly a decade of leadership, Margaret Grayson MBE reflects on her time as Chair of the #CancerGrandChallenges Advocacy Panel. Thank you Margaret for embedding the voices of those affected by cancer into discovery research.

features.cancerresearchuk.org/cancergrandc...
DFS 0161 CGC Discover mag 2024 — Patient advocacy
A year of scientific creativity
features.cancerresearchuk.org
cancergrand.bsky.social
Prof Kimmie Ng, one of our leading #CancerGrandChallenges scientists, discusses the drivers behind early onset colorectal cancer with ‪The New York Times #EOCRC

nytimes.com/2025/08/02/w...
How Your Diet Influences Your Colorectal Cancer Risk
nytimes.com